申请人:SANKYO COMPANY LIMITED
公开号:EP0641769A1
公开(公告)日:1995-03-08
Constitution: an amino acid derivative represented by the general formula (I): R¹NH-CH(R²)-CONH-A-ONO₂ and a pharmacologically acceptable salt thereof, wherein R¹ represents hydrogen, C₁-C₇ alkanoyl, C₁-C₆ alkoxycarbonyl, C₆-C₁₀ arylcarbonyl, C₇-C₁₃ aralkylcarbonyl, C₇-C₁₃ aralkyloxycarbonyl, or 5- or 6-membered heteroarylcarbonyl; R² represents substituted C₁-C₆ alkyl; and A represents C₂-C₅ alkylene. Effect: this compound is excellent in a collateral vessel dilator activity and an antianginal activity, and hence useful as an antianginal drug.
构成:通式(I)代表的氨基酸衍生物:R¹NH-CH(R²)-CONH-A-ONO₂ 及其药理学上可接受的盐,其中 R¹ 代表氢、C₁-C₇ 烷酰基C₁-C₆烷氧基羰基、C₆-C₁₀芳基羰基、C₇-C₁₃ 芳基羰基、C₇-C₁₃ 芳基氧基羰基或 5 或 6 元杂芳基羰基;R² 代表取代的 C₁-C₆ 烷基;以及 A 代表 C₂-C₅ 亚烷基。功效:该化合物具有良好的扩张侧支血管活性和抗心绞痛活性,因此可用作抗心绞痛药物。